Aytu Biopharma (AYTU) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026)
Powered by 
Analysis
Aytu Biopharma (AYTU) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.24 Bn | 623.49 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 443.24 Bn | 436.67 Bn | 12.70 Bn | 5.45% |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | 5.00% |
| 4 | Novartis Ag | 266.33 Bn | 258.64 Bn | 11.24 Bn | -0.43% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 2.85% |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn | 3.06% |
| 7 | Revolution Medicines | 44.03 Bn | 44.03 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.82 Bn | 1.57 Bn | -1.81% |
| 9 | United Therapeutics | 21.58 Bn | 18.92 Bn | 683.80 Mn | 27.15% |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -41.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -41.45% |
| Dec 31, 2025 | -40.89% |
| Sep 30, 2025 | -42.80% |
| Jun 30, 2025 | -43.97% |
| Mar 31, 2025 | -46.06% |
| Dec 31, 2024 | -50.65% |
| Sep 30, 2024 | -47.07% |
| Jun 30, 2024 | -48.72% |
| Dec 31, 2023 | 132.51% |
| Sep 30, 2023 | 153.14% |
| Jun 30, 2023 | 91.36% |
| Mar 31, 2023 | 91.58% |
| Dec 31, 2022 | 167.79% |
| Sep 30, 2022 | 168.59% |
| Jun 30, 2022 | 145.78% |
| Mar 31, 2022 | 151.32% |
| Dec 31, 2021 | 184.26% |
| Sep 30, 2021 | 187.47% |
| Jun 30, 2021 | 186.45% |
| Dec 31, 2020 | -45.72% |